Trials / Withdrawn
WithdrawnNCT02190565
Safety and Efficacy Study of a Food Supplement for Pregnant and Lactating Women
Supplementation With WellnessPack Mama During Pregnancy and Lactation - a Randomized Double-blind, Placebo-controlled Study
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Oriflame Cosmetics AB · Industry
- Sex
- Female
- Age
- 18 Years – 40 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this study is to determine whether a food supplement consisting of vitamins, minerals and fish oil taken during and after pregnancy can decrease the need for additional iron supplementation due to anemia during pregnancy, and optimize levels of nutritional markers such as vitamin D and docosahexaenoic acid (DHA, an omega 3 fatty acid) in maternal blood and breast milk, compared to placebo.
Detailed description
200 healthy, pregnant women will be randomized to receive either active or placebo at their first visit to the pre-natal centres. They will be monitored at regular intervals, blood samples will be taken and they will be asked about compliance and any adverse reactions. Approx 8 weeks after delivery, the women will come to the pre-natal centres for a check-up. During this visit, a blood sample will be drawn and a breast milk sample will be collected. The blood samples will be analysed for haemoglobin, serum ferritin, vitamin D and DHA. The breast milk samples will be analysed for vitamin D and DHA.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Food supplement | Randomized double-blind, placebo-controlled |
Timeline
- Start date
- 2018-04-07
- Primary completion
- 2018-04-07
- Completion
- 2018-04-07
- First posted
- 2014-07-15
- Last updated
- 2018-12-05
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT02190565. Inclusion in this directory is not an endorsement.